专题:Pharmaceutical industry and healthcare

This cluster of papers explores the impact of pharmaceutical industry sponsorship on research outcome and quality, including conflicts of interest, financial ties between physicians and industry, direct-to-consumer advertising, publication bias, and ethical considerations in medical practice. The papers investigate the influence of funding sources on clinical trials, prescribing behavior, and the integrity of medical science.
最新文献
Conflicts of Interest in Federal Vaccine Advisory Committees

article Full Text OpenAlex

Hijacked medical journals rank first via search engine optimization and threaten academic integrity

article Full Text OpenAlex

A Scoping Review of Published Literature on the Contributions of the Natural Health Products (NHPs) Industry to Pharmacovigilance for NHPs

review Full Text OpenAlex

UK government promises crackdown on “cowboy cosmetic procedures” amid rise in rogue providers

article Full Text OpenAlex

Unsolicited Patient Complaints and Industry Payments for US Physicians

article Full Text OpenAlex

Psychographic Profiles of Healthcare Professionals and Their Impact on Prescribing Behaviour

book-chapter Full Text OpenAlex

“We didn’t used to be corporate medicine”: The jobification of United States healthcare

article Full Text OpenAlex

Asymmetric evaluations of scientific evidence indicating harm compared to evidence indicating an absence of harm in regulatory appraisals

article Full Text OpenAlex

Michigan Ophthalmology Pathway Program: Five Years of Aiming to Increase Diversity in Ophthalmology

article Full Text OpenAlex

The Role of Validation in Mitigating Non-Compliance in the Pharmaceutical Industry

article Full Text OpenAlex

近5年高被引文献
Responsible Conduct of Research

book Full Text OpenAlex 200 FWCI45.765

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

article Full Text OpenAlex 184 FWCI36.451

Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets

paratext Full Text OpenAlex 130 FWCI0

Medication Without Harm

article Full Text OpenAlex 124 FWCI15.643

Impact of Patient Engagement on Healthcare Quality: A Scoping Review

review Full Text OpenAlex 114 FWCI8.252

Market strategies used by processed food manufacturers to increase and consolidate their power: a systematic review and document analysis

review Full Text OpenAlex 113 FWCI5.219

The gendered nature of authorship

article Full Text OpenAlex 108 FWCI5.127

The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice

article Full Text OpenAlex 96 FWCI10.873

Trends in Prescription Drug Launch Prices, 2008-2021

article Full Text OpenAlex 85 FWCI14.17

PRILE 2021 guidelines for reporting laboratory studies in Endodontology: explanation and elaboration

review Full Text OpenAlex 85 FWCI3.535